Abstract: An object of the present disclosure is to implement, at a low cost, highly accurate color calibration in a printing apparatus that performs printing using fluorescent ink. One embodiment of the present invention is an image processing apparatus that includes: a processing unit configured to perform processing relating to color calibration in a printing apparatus that prints an image on a printing medium using fluorescent printing material; and an execution unit configured to perform calibration processing of the printing apparatus based on a measured value that is obtained by measuring a patch chart for obtaining information on an amount of application of the fluorescent printing material in the printing apparatus, wherein a patch included in the patch chart is printed with the fluorescent printing material and subtractive color mixture printing material and at least one dot of the subtractive color mixture printing material covers a dot of the fluorescent printing material.

Abstract: A connecting tube portion protrudes outward from an outer wall of the main pipe and is continuous with the interior of the main pipe. The connecting tube portion has an annular groove, into which the distal end of the branch pipe is fitted, at the distal end. The branch pipe includes an outer circumference seal portion that provides a seal between the outer circumferential surface of the distal end of the branch pipe and the inner surface of the annular groove of the connecting tube portion through contact between the outer circumferential surface and the inner surface. The branch pipe also includes an inner circumference seal portion that provides a seal between the inner circumferential surface of the distal end of the branch pipe and the inner surface of the annular groove of the connecting tube portion through contact between the inner circumferential surface and the inner surface.

Abstract: A storage battery is charged with power supplied from at least one of a commercial power system and an independent power source, and supplies the charged power to a plurality of electric devices or the commercial power system. A control unit switches the operation state of the storage battery to either charging or discharging, and switches connection destinations of the storage battery. When the commercial power system is not in a power outage state, the control unit supplies power from the storage battery to the electric devices or the commercial power system only if the remaining level of the storage battery exceeds a reference value.

Abstract: A compound represented by the following general formula (1) or a salt thereof, which has superior inhibitory activity against type 4 PLA2, and thus has prostaglandin and/or leucotriene production suppressing action [X represents a halogen atom, an alkyl group which may be substituted, or the like, Y represents hydrogen atom or an alkyl group which may be substituted, and Z represents hydrogen atom or an alkyl group which may be substituted].

Abstract: A compound represented by the following general formula (1) or a salt thereof, which has superior inhibitory activity against type 4 PLA2, and thus has prostaglandin and/or leucotriene production suppressing action [X represents a halogen atom, an alkyl group which may be substituted, or the like, Y represents hydrogen atom or an alkyl group which may be substituted, and Z represents hydrogen atom or an alkyl group which may be substituted].

Abstract: A compound represented by the following general formula (1) or a salt thereof, which has superior inhibitory activity against type 4 PLA2, and thus has prostaglandin and/or leucotriene production suppressing action [X represents a halogen atom, an alkyl group which may be substituted, or the like, Y represents hydrogen atom or an alkyl group which may be substituted, and Z represents hydrogen atom or an alkyl group which may be substituted].

Abstract: A storage battery is charged with power supplied from at least one of a commercial power system and an independent power source, and supplies the charged power to a plurality of electric devices or the commercial power system. A control unit switches the operation state of the storage battery to either charging or discharging, and switches connection destinations of the storage battery. When the commercial power system is not in a power outage state, the control unit supplies power from the storage battery to the electric devices or the commercial power system only if the remaining level of the storage battery exceeds a reference value.

Abstract: According to one embodiment, a movable apparatus includes a carriage, coaxial paired wheels configured to support the carriage, a wheel actuator configured to rotationally drive the paired wheels, a loading section provided above the carriage, a swinging section includes a first swinging mechanism configured to swing the loading section around a first shaft extending in a direction crossing an axle of the wheels and a second swinging mechanism configured to swing the loading section around a second shaft provided parallel to the axle, acceleration sensing device configured to measure accelerations, and a swing angle control device configured to control the swing angle of each of the first swinging mechanism and the second swinging mechanism, to swing the loading section in a direction in which a component force of the acceleration applied to the loading section in a horizontal direction and a component force of gravity are balanced.

Abstract: A compound represented by the following general formula (1) or a salt thereof, which has superior inhibitory activity against type 4 PLA2, and thus has prostaglandin and/or leucotriene production suppressing action [X represents a halogen atom, an alkyl group which may be substituted, or the like, Y represents hydrogen atom or an alkyl group which may be substituted, and Z represents hydrogen atom or an alkyl group which may be substituted].

Abstract: An optical diaphragm for adjusting a light quantity of an incident light beam includes: a plurality of light-shielding vanes attached to a circumferential portion of an aperture of a base plate in a manner rotatable along a plane orthogonal to an optical axis of the light beam. The light-shielding vanes may be rotated to change an aperture area of the aperture of the base plate for transmitting the light beam. The plurality of light-shielding vanes each include a vane plate for intercepting the incident light beam; and a bearing integrally provided to the vane plate, the bearing each allowing a rotary shaft to be inserted therein so as to be supported by the rotary shaft. The vane plate is perpendicularly attached to the bearing. The plurality of light-shielding vanes move parallel to each other in an opening and closing direction thereof without crossing with each other.

Abstract: A compound represented by the formula (I): [In the formula, Link represents a saturated or unsaturated straight hydrocarbon chain having 1 to 3 carbon atoms, C2 to C6 in the aromatic ring (E) independently represent a ring-constituting carbon atom, one of the ring-constituting carbon atoms may be replaced with V, V represents nitrogen atom, or carbon atom substituted with Zx, Zx represents a saturated alkyl group having 1 to 4 carbon atoms and the like, Rs represents -D-Rx etc., D represents a single bond, oxygen atom and the like, Rx represents a saturated alkyl group having 3 to 8 carbon atoms and the like, AR represents a partially unsaturated or completely unsaturated condensed bicyclic carbon ring or a heterocyclic ring, and Y represents hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms and the like] or a salt thereof. A compound having prostaglandin production-suppressing action and leukotriene production-suppressing action is provided.

Abstract: [Object] To provide a compound having prostaglandin production-suppressing action and leukotriene production-suppressing action. [Means for Solution] A compound represented by the formula (I): [In the formula, represents a single bond, or a double bond, Link represents a single bond, or a saturated or unsaturated straight hydrocarbon having 1 or 2 carbon atoms, W represents a single bond, oxygen atom, sulfur atom, N(Rw) etc., Rw represents hydrogen atom, an alkyl group having 1 to 8 carbon atoms etc, Rs represents -D-Rx etc., D represents a single bond, oxygen atom, sulfur atom etc., Rx represents a linear or branched saturated alkyl group having 3 to 8 carbon atoms etc., one of V1 and V2 represents Zx, and the other represents AR, Zx represents hydrogen atom, a linear or branched saturated alkyl group having 1 to 4 carbon atoms etc.

Abstract: A compound represented by the formula (I): [In the formula, Link represents a saturated or unsaturated straight hydrocarbon chain having 1 to 3 carbon atoms, C2 to C6 in the aromatic ring (E) independently represent a ring-constituting carbon atom, one of the ring-constituting carbon atoms may be replaced with V, V represents nitrogen atom, or carbon atom substituted with Zx, Zx represents a saturated alkyl group having 1 to 4 carbon atoms and the like, Rs represents -D-Rx etc., D represents a single bond, oxygen atom and the like, Rx represents a saturated alkyl group having 3 to 8 carbon atoms and the like, AR represents a partially unsaturated or completely unsaturated condensed bicyclic carbon ring or a heterocyclic ring, and Y represents hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms and the like] or a salt thereof. A compound having prostaglandin production-suppressing action and leukotriene production-suppressing action is provided.

Abstract: A compound represented by the formula (I): [In the formula, Link represents a saturated or unsaturated straight hydrocarbon chain having 1 to 3 carbon atoms, C2 to C6 in the aromatic ring (E) independently represent a ring-constituting carbon atom, one of the ring-constituting carbon atoms may be replaced with V, V represents nitrogen atom, or carbon atom substituted with Zx, Zx represents a saturated alkyl group having 1 to 4 carbon atoms and the like, Rs represents -D-Rx etc., D represents a single bond, oxygen atom and the like, Rx represents a saturated alkyl group having 3 to 8 carbon atoms and the like, AR represents a partially unsaturated or completely unsaturated condensed bicyclic carbon ring or a heterocyclic ring, and Y represents hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms and the like] or a salt thereof. A compound having prostaglandin production-suppressing action and leukotriene production-suppressing action is provided.

Abstract: An optical diaphragm for adjusting a light quantity of an incident light beam includes: a base plate extending along a plane orthogonal to an optical axis of the light beam, the base plate having an aperture for transmitting the light beam; a plurality of light-shielding vanes attached to a circumferential portion of the aperture of the base plate in a manner rotatable along the plane orthogonal to the optical axis of the light beam, the light-shielding being rotated to change an aperture area of the aperture for transmitting the light beam to adjust the light quantity of the light beam; a vane holder for pressing the plurality of light-shielding vanes to the base plate in a manner that the light-shielding vanes are rotatable; a plurality of rotary shafts fixed between the base plate and the vane holder, the rotary shafts each rotatably supporting each of the plurality of light-shielding vanes; and a vane-driving mechanism movably attached to the base plate and engaged with the plurality of light-shielding va

Abstract: A compound represented by the formula (I) or a salt thereof: wherein n represents an integer of 1 to 3, R represents an alkyl group having 3 to 8 carbon atoms, a group represented by the following formula: R1(CH2)k— (wherein k represents 0 or an integer of 1 to 3; R1 represents a saturated cyclic alkyl group having 3 to 7 carbon atoms or a saturated condensed cyclic alkyl group having 6 to 8 carbon atoms, and the group R1 may be substituted with a lower alkyl group having 1 to 4 carbon atoms) and the like, and Ar represents a condensed bicyclic group such as naphthalen-1-yl group, which has suppressing action on prostaglandin and leukotriene production and is useful for prophylactic and/or therapeutic treatment of various inflammatory diseases and the like caused by these lipid mediators.

Abstract: The present invention has its objects to provide a novel polypeptide having water channel activity and to a DNA sequence encoding for the polypeptide. This invention is related to a novel polypeptide having water channel activity which has the amino acid sequence, within the molecule thereof, shown in the sequence listing under SEQ ID NO: 1.

Abstract: A compound represented by the formula (I) or a salt thereof: 1

Abstract: Disclosed is a drug complex of a drug having a hydroxyl group, which is capable of controlling the rate of the release of the drug therefrom in blood, the drug complex being represented by the following formula (1): A—B—C  (1) wherein A represents at least one carrier selected from the group consisting of saccharides each having a carboxyl group, polyethylene glycols each having a carboxyl group, aliphatic carboxylic acids each having a carboxyl group, and derivatives thereof each having a carboxyl group; B represents at least one spacer comprised of a compound having a amino group and a carboxyl group; C represents at least one drug having a hydroxyl group, wherein the carrier A is bonded to the spacer B through an amide bond formed between the carboxyl group of the carrier A and the amino group of the spacer B; and the spacer B is bonded to the drug C through an ester bond formed between the carboxyl group of the spacer B and the hydroxyl group of the drug C.

Abstract: The present invention has its objects to provide a novel polypeptide having water channel activity and to a DNA sequence encoding for the polypeptide.